Polycythemia Vera is best described as?

• A. A chronic myeloproliferative neoplasm characterized by excessive production of RBCs, WBCs, and platelets
• B. A hypoproliferative anemia
• C. A malignant lymphoid proliferation
• D. A disease with isolated platelet deficiency

Answer: (A)

Polycythemia Vera is a chronic myeloproliferative neoplasm arising from a clonal hematopoietic stem cell that drives increased production of all three myeloid cell lines—red cells, white cells, and platelets. This results in elevated red cell mass (high hemoglobin/hematocrit) and often high counts of white cells and platelets, with symptoms mainly related to hyperviscosity and thrombosis risk. This description fits PV best because it reflects a clonal overproduction of multiple blood cell lineages, not a deficiency or restricted proliferation.

It is not a hypoproliferative anemia, which would involve inadequate production of red cells. It is not a malignant lymphoid proliferation, since PV concerns myeloid lineage cells rather than lymphoid cells. It is not a disease with isolated platelet deficiency, as PV typically features elevated platelets (and often elevated other lineages) rather than a lack of platelets.